Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

Drug Sales Trends for HUMIRA PEN

Email this page to a colleague

« Back to Dashboard

Payment Methods and Pharmacy Types for HUMIRA PEN (2019)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
MAIL-ORDER	$4,693,570,702
INSIDE ANOTHER STORE	$3,037,677,110
[disabled in preview]	$2,062,176,021
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
MAIL-ORDER	563,694
INSIDE ANOTHER STORE	500,208
[disabled in preview]	284,389
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICAID	$89,788,989
MEDICARE	$2,823,307,472
[disabled in preview]	$6,880,327,372
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for HUMIRA PEN

Drug Units Sold Trends for HUMIRA PEN

Annual Sales Revenues and Units Sold for HUMIRA PEN

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or Try it Free
Drug Name	Revenues (USD)	Units	Year
HUMIRA PEN	⤷ Try it Free	⤷ Try it Free	2019
HUMIRA PEN	⤷ Try it Free	⤷ Try it Free	2018
HUMIRA PEN	⤷ Try it Free	⤷ Try it Free	2017
>Drug Name	>Revenues (USD)	>Units	>Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

Dow

Mallinckrodt

Harvard Business School

Merck

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.